Page 472 - ES 2020-21_Volume-1-2 [28-01-21]

External Sector 99

Reference
Bhalla, S. S. (2019). Report of the High Level Advisory Group. Department of Commerce,
Government of India.

Invest India. (n.d.). Retrieved from Invest India: https://www.investindia.gov.in/sector/
pharmaceuticals
Mahajan, V., Nauriyal, D., & Singh, S. (2015). Trade Performance and revealed
comparative advantage of Indian pharmaceutical industry in new IPR regime. International
Journal of Pharmaceutical and Healthcare Marketing.

(June, 2019). The Indian Pharmaceutical Industry- the way forward. Indian Pharmaceutical
Alliance. Retrieved from https://www.ipa-india.org/wp-content/uploads/2020/10/indian-
pharmaceutical-industry-way-forward.pdf

3.13 In so far as the top export destinations are concerned, USA continues to be the largest export
market for India in April-November, 2020, while China has occupied the 2 position, moving
nd
up from 3 spot in April-November, 2019. Exports to China in April-November, 2020 constitute
rd
around 7.8 per cent vis-à-vis 5.4 per cent in April-November, 2019 (Figure 7). Malaysia is a new
entrant among the top 10 export destinations, as compared to last year, while Nepal no longer
occupies position among the top 10 destinations.

Figure 7: Top 10 Export Destinations in April-November 2020 and April-November 2019
[By Share in Per cent]

18.0 % Share in Apr-Nov 2020 % Share in Apr-Nov 2019
18 16.9
16
14
12 9.3
Per cent 10 7.8
8
6 5.4 5.6
3.7 3.7
4 3.2 3.1 2.9 2.5 2.8 2.6 2.6 2.7 2.3 2.2 2.7 2.3
2
0
U S A China PRP UAE Hong Kong Singapore Bangladesh PR Germany U K Malaysia Netherlands Nepal

Source: DoC
Merchandise Imports

3.14 The total imports during April-December, 2020 amounted to US$ 258.3 billion contracted
by (-) 29.1 per cent, as compared with (-) 7.2 per cent during the same period last year. The sharp
decline in POL imports that constitute about a quarter of total merchandise imports pulled down
the overall import growth (Figure 8). During this period, the value of POL imports plummeted